Have you or your loved ones been diagnosed with urothelial carcinoma?

You may be eligible to participate in a urothelial carcinoma clinical trial.

Have you or your loved ones been diagnosed with urothelial carcinoma? You may be eligible to participate in a urothelial carcinoma clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Urothelial Carcinoma Clinical Trial in Omaha NE
NCT03606174 | Phase 2 | Interventional

Have you or your loved ones been diagnosed with urothelial carcinoma?

You may be eligible to participate in a urothelial carcinoma clinical trial.

Have you or your loved ones been diagnosed with urothelial carcinoma? You may be eligible to participate in a urothelial carcinoma clinical trial.

Recruiting

Male & Female

18 Years +

This study is looking to recruit 425 Participants

The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibitor regimens in combination with the investigational agent sitravatinib in patients with advanced or metastatic urothelial carcinoma.